Literature DB >> 10330803

Hemorrhagic cerebellar metastasis from papillary thyroid carcinoma.

C K Lin1, A S Lieu, S L Howng.   

Abstract

Papillary thyroid carcinoma has a low incidence of distant metastases. Brain metastasis is extremely rare with a frequency of 0.1-1.3%. In the present series, the rate was 1.5%, only two cases had cerebral metastases in 136 patients with papillary thyroid carcinoma from January 1988 to April 1998. Cerebellar metastasis is even rarer, and solitary cerebellar metastasis has not been reported to the best of our knowledge. Two cases of papillary thyroid carcinoma with cerebellar metastases presenting as tumor hemorrhage are reported. In one patient, the lesion was in the bilateral cerebellar hemispheres with obstructive hydrocephalus. After operation, the patient had an uneventful course with recovery of her consciousness. In the other, the solitary lesion was in the left cerebellar hemisphere without obstructive hydrocephalus. After surgical treatment, the patient had a smooth course with resolution of his neurological deficit. It shows the importance of surgery in the management of a hemorrhagic cerebellar metastasis from papillary thyroid carcinoma, not only in reducing acute aggravating cerebral symptoms, but also in prolonging survival time.

Entities:  

Mesh:

Year:  1999        PMID: 10330803

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  3 in total

1.  Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer.

Authors:  In-Young Kim; Douglas Kondziolka; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2009-01-13       Impact factor: 4.130

2.  Cerebellum as Initial Site of Distant Metastasis from Papillary Carcinoma of Thyroid: Review of Three Cases.

Authors:  Mutahir A Tunio; Mushabbab Al Asiri; Khalid Hussain Al-Qahtani; Wafa AlShakweer
Journal:  Case Rep Neurol Med       Date:  2015-05-06

3.  Clinico-radiological features of brain metastases from thyroid cancer.

Authors:  Song Soo Kim; Seok-Mo Kim; Mina Park; Sang Hyun Suh; Sung Jun Ahn
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.